About Theraclion
Theraclion is a company based in Malakoff (France) founded in 2004.. Theraclion has raised $4.5 million across 6 funding rounds from investors including Natixis, European Union and Inner Mongolia Furui Medical Science. Theraclion offers products and services including SONOVEIN, ECHOPULSE, and EPack. Theraclion operates in a competitive market with competitors including Insightec, HistoSonics, Profound Medical, Carthera and SONIRE Therapeutics, among others.
- Headquarter Malakoff, France
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$4.24 M (USD)187as on Dec 31, 2023
-
Net Profit
$-3.98 M (USD)26as on Dec 31, 2023
-
EBITDA
$-5.31 M (USD)20as on Dec 31, 2023
-
Total Equity Funding
$4.5 M (USD)
in 6 rounds
-
Latest Funding Round
$10.57 M (USD), Post-IPO
Jul 23, 2016
-
Investors
Natixis
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Theraclion
Theraclion offers a comprehensive portfolio of products and services, including SONOVEIN, ECHOPULSE, and EPack. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive device for treating varicose veins using focused ultrasound.
Non-invasive system for thyroid nodules and breast fibroadenoma treatments.
Supportive component for echotherapy platforms in medical applications.
Funding Insights of Theraclion
Theraclion has successfully raised a total of $4.5M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10.57 million completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $10.6M
-
First Round
First Round
(02 May 2005)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Post-IPO - Theraclion | Valuation |
investors |
|
| Dec, 2015 | Amount | Post-IPO - Theraclion | Valuation |
investors |
|
| Jun, 2015 | Amount | Post-IPO - Theraclion | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Theraclion
Theraclion has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Natixis, European Union and Inner Mongolia Furui Medical Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Truffle Capital is recognized as a leading European venture capital firm.
|
Founded Year | Domain | Location | |
|
Therapeutic and diagnostic solutions for liver diseases are provided.
|
Founded Year | Domain | Location | |
|
Diversified investment management services are provided globally by Aviva Investors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Theraclion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Theraclion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theraclion Comparisons
Competitors of Theraclion
Theraclion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, HistoSonics, Profound Medical, Carthera and SONIRE Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
|
|
| domain | founded_year | HQ Location |
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
|
|
| domain | founded_year | HQ Location |
Image-guided prostate ablation systems for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Ultrasound-based medical devices for brain tumor treatment are developed.
|
|
| domain | founded_year | HQ Location |
High-intensity focused ultrasound systems for targeted cancer treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theraclion
Frequently Asked Questions about Theraclion
When was Theraclion founded?
Theraclion was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Where is Theraclion located?
Theraclion is headquartered in Malakoff, France. It is registered at Malakoff, Ile-de-france, France.
Who is the current CEO of Theraclion?
Martin Deterre is the current CEO of Theraclion.
Is Theraclion a funded company?
Theraclion is a funded company, having raised a total of $4.5M across 6 funding rounds to date. The company's 1st funding round was a Post-IPO of $476K, raised on May 02, 2005.
What is the annual revenue of Theraclion?
Annual revenue of Theraclion is $4.24M as on Dec 31, 2023.
What does Theraclion do?
Theraclion was founded in 2004 and is headquartered in Malakoff, France. Operations focus on the medical device sector, where non-invasive robotic platforms using high-intensity focused ultrasound (HIFU) guided by real-time monitoring are developed. Sonovein is utilized for thermal ablation of varicose veins, while Echopulse targets thyroid nodules and breast fibroadenomas without surgical intervention. These systems enable treatments free of incisions, scars, or anesthesia.
Who are the top competitors of Theraclion?
Theraclion's top competitors include Insightec, HistoSonics and Profound Medical.
What products or services does Theraclion offer?
Theraclion offers SONOVEIN, ECHOPULSE, and EPack.
Who are Theraclion's investors?
Theraclion has 5 investors. Key investors include Natixis, European Union, Inner Mongolia Furui Medical Science, Aviva Investors, and Truffle Capital.